Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GenMark Diagnostics Inc. GNMK

Healthcare
GenMark Diagnostics Inc is a provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. The company currently operates in one reportable business segment, which encompasses the development, manufacturing, sales, and support of instruments and molecular tests based on its proprietary... see more

Recent & Breaking News (NDAQ:GNMK)

GenMark Diagnostics Schedules Second Quarter Financial Results Conference Call for July 30, 2018

GlobeNewswire July 16, 2018

GenMark Diagnostics Announces FDA Submission of its ePlex Blood Culture Identification Gram Positive Panel

GlobeNewswire June 28, 2018

GenMark Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference

GlobeNewswire June 6, 2018

GenMark Diagnostics to Present at the Bank of America Merrill Lynch 2018 Health Care Conference

GlobeNewswire May 2, 2018

GenMark Diagnostics Reports First Quarter 2018 Results

GlobeNewswire May 1, 2018

GenMark Diagnostics Schedules First Quarter Financial Results Conference Call for May 1, 2018

GlobeNewswire April 17, 2018

GenMark Diagnostics Reports Fourth Quarter and Full Year 2017 Results

GlobeNewswire February 27, 2018

GenMark Diagnostics, Inc. to Host Earnings Call

Accesswire February 27, 2018

GenMark Diagnostics to Present at Upcoming Investor Conferences

GlobeNewswire February 21, 2018

GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2017

GlobeNewswire January 9, 2018

GenMark Diagnostics to Present at the J.P. Morgan 36th Annual Healthcare Conference

GlobeNewswire December 21, 2017

Factors of Influence in 2018, Key Indicators and Opportunity within Waste Connections, Hercules Capital, Scientific Games, GenMark Diagnostics, Clorox, and Cavium — New Research Emphasizes Economic Growth

GlobeNewswire November 21, 2017

Lifshitz & Miller LLP Announces Investigation of CBBC Bancorp, Clifton Bancorp Inc., Dynegy, Inc., GenMark Diagnostics, Inc., Impax Laboratories, Inc., RPM International Inc. and XBiotech Inc.

PR Newswire November 16, 2017

GNMK INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation on Behalf of GenMark Diagnostics, Inc. Investors

Business Wire November 14, 2017

ACT NOW: Monteverde & Associates PC Announces an Investigation of GenMark Diagnostics, Inc. - GNMK

PR Newswire November 11, 2017

Glancy Prongay & Murray LLP Continues Investigation on Behalf of GenMark Diagnostics, Inc. Investors (GNMK)

Business Wire November 10, 2017

GNMK INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of GenMark Diagnostics, Inc. Investors

Business Wire November 8, 2017

GenMark Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

Business Wire November 7, 2017

Glancy Prongay & Murray LLP Commences Investigation on Behalf of GenMark Diagnostics, Inc. Investors (GNMK)

Business Wire November 3, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GenMark Diagnostic, Inc. - GNMK

PR Newswire November 3, 2017